Novartis AG & Anor v Teva UK Ltd & Ors [2022] EWHC 959 (Ch) (26 April 2022)

Novartis AG & Anor v Teva UK Ltd & Ors [2022] EWHC 959 (Ch) (26 April 2022)

The court has jurisdiction to grant interim injunctive relief pre-grant of a patent, but in this case, damages would be an adequate remedy for Novartis and the balance of convenience does not favour granting the injunction; therefore, interim relief is refused.

Citation
[2022] EWHC 959 (Ch)
Parties
Claimant: Novartis AG; Claimant: Novartis Pharmaceuticals UK Limited; Defendant: Teva UK Limited; Defendant: Dr. Reddy's Laboratories (UK) Limited; Defendant: Glenmark Pharmaceuticals Europe Limited; Defendant: Tillomed Laboratories Limited; Defendant: Zentiva Pharma UK Limited; Defendant: Aristo Pharma GmbH
Jurisdiction
England and Wales
Judgment Date
26 April 2022
Procedural Posture
Interim Injunction Application in Patent Infringement Proceedings / Interim Relief (pre Trial)
Outcome
Application for interim injunction refused
Legal Topics
Interim Injunctions, Patent Infringement, Jurisdiction Pre Grant, Adequacy of Damages, Balance of Convenience
Intellectual Property Patents Interim Injunctions Patent Infringement Jurisdiction Pre Grant Adequacy of Damages Balance of Convenience

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 12 Party arguments 2 Amounts and remedies 3
Sign in to unlock

Parties

Novartis AG

Claimant

Novartis Pharmaceuticals UK Limited

Claimant

Teva UK Limited

Defendant

Dr. Reddy's Laboratories (UK) Limited

Defendant

Glenmark Pharmaceuticals Europe Limited

Defendant

Tillomed Laboratories Limited

Defendant

Zentiva Pharma UK Limited

Defendant

Aristo Pharma GmbH

Defendant

Procedural Posture

Interim Injunction Application in Patent Infringement Proceedings / Interim Relief (pre Trial)

Legal Issues

  1. 1 Does the court have jurisdiction to grant an interim injunction pre-grant of a patent?
  2. 2 Should interim injunctive relief be granted to restrain generic entry before patent grant?

Ratio Decidendi

The court has jurisdiction to grant interim injunctive relief pre-grant of a patent, but in this case, damages would be an adequate remedy for Novartis and the balance of convenience does not favour granting the injunction; therefore, interim relief is refused.

Court Disposition

Application for interim injunction refused

Orders

  • Interim injunction refused; no interim relief granted